Jump to content

Recommended Posts

Posted

It seems now the Qdenga vaccine gets recommended by many countries even for seronegatives. Many countries still recommend against it for seronegatives though:

 

https://academic.oup.com/jtm/article/32/3/taaf023/8064715

 

According to ChatGPT the vaccine affords low protection (something like 40%) against infection, but high protection (80%) against hospitalisation. This is reminiscent of the Covid vaccines (please no rant about the Covid vaccines!)

 

I'm still sitting on the fence.

Posted
3 hours ago, JackGats said:

It seems now the Qdenga vaccine gets recommended by many countries even for seronegatives. Many countries still recommend against it for seronegatives though:

 

https://academic.oup.com/jtm/article/32/3/taaf023/8064715

 

According to ChatGPT the vaccine affords low protection (something like 40%) against infection, but high protection (80%) against hospitalisation. This is reminiscent of the Covid vaccines (please no rant about the Covid vaccines!)

 

I'm still sitting on the fence.

 

The WHO position paper that your linked article references in regard to Qdenga for seronegative individuals, states the following: 

 

Quote

Until the efficacy–risk profile for DENV3 and DENV4 in seronegative persons has been more thoroughly assessed, WHO does not recommend the programmatic use of TAK-003 [Qdenga] vaccine in low to moderate dengue transmission settings.

 

So unless you're at high risk of Dengue infection, maybe Qdenga is not really indicated at this time (until more data is available).

 

However the efficacy figures the WHO paper gives are much higher.

 

Quote

During the 51 months of follow-up, seropositivity rates in baseline seronegative subjects consistently

remained >98% against DENV2, and >80% against the other 3 serotypes.

 

https://www.who.int/publications/i/item/who-wer-9918-203-224?form=MG0AV3

  • Like 1
  • Thanks 1
Posted

On the other hand, the paper also states that the data on risks for seronegative individuals for DENV3 and 4 is limited, precisely because infections with those serotypes is less common. That seems to be true for Thailand also. 

 

"In Thailand, DENV-2 and DENV-1 are the most common dengue serotypes, although DENV-3 and DENV-4 also circulate. Studies in Southern Thailand and other regions have shown DENV-2 as a dominant serotype in some years, followed by DENV-1, DENV-3, and DENV-4."

 

Epidemiology and costs of Dengue in Thailand

 

https://pmc.ncbi.nlm.nih.gov/articles/PMC9810168/

 

So it seems as though the risk of getting DENV3 or 4 is lower that for the other two serotypes.

Posted
6 minutes ago, LosLobo said:

Seems there may be some limitations on age group over 60 in Thailand based on limited clinical data for that particular group.

'Can be administered to anybody 4 – 60 years old'

https://www.bangkokhospital.com/en/content/dengue-vaccine

True, but there's no a priori reason for supposing that the vaccine will not work, or will have any significantly different safety profile in people over 60, as far as I'm aware.

Posted
9 minutes ago, GroveHillWanderer said:

True, but there's no a priori reason for supposing that the vaccine will not work, or will have any significantly different safety profile in people over 60, as far as I'm aware.


I agree — and in the West, you can usually discuss it with your healthcare provider, and based on their assessment, they would likely approve it if appropriate.

Posted
5 hours ago, GroveHillWanderer said:

On the other hand, the paper also states that the data on risks for seronegative individuals for DENV3 and 4 is limited, precisely because infections with those serotypes is less common. That seems to be true for Thailand also. 

 

"In Thailand, DENV-2 and DENV-1 are the most common dengue serotypes, although DENV-3 and DENV-4 also circulate. Studies in Southern Thailand and other regions have shown DENV-2 as a dominant serotype in some years, followed by DENV-1, DENV-3, and DENV-4."

 

Epidemiology and costs of Dengue in Thailand

 

https://pmc.ncbi.nlm.nih.gov/articles/PMC9810168/

 

So it seems as though the risk of getting DENV3 or 4 is lower that for the other two serotypes.

What I'd like to know is the following: is the high protection (80%) against hospitalisation also valid for seronegative individuals, or does this figure conflate seronegatives with seropositives? If the vaccine does nothing to protect seronegatives from severe illness, or puts them at slightly more risks than non-vaccinated, better wait till you've had dengue once before getting vaccinated.

Posted
On 4/23/2025 at 5:35 PM, JackGats said:

What I'd like to know is the following: is the high protection (80%) against hospitalisation also valid for seronegative individuals, or does this figure conflate seronegatives with seropositives? If the vaccine does nothing to protect seronegatives from severe illness, or puts them at slightly more risks than non-vaccinated, better wait till you've had dengue once before getting vaccinated.

The efficacy rates given in the WHO position paper I linked to earlier listed the figures for both seropositive and seronegative individuals, and for both infection and hospitalisation, for all four serotypes.

 

Those figures are as follows (VCD stands for virologically-confirmed Dengue):

 

Quote

When stratified by virus serotype and baseline serostatus, 57 months after the first dose, the efficacy against DENV1 VCD was 56% in seropositive subjects, and 45% in seronegative subjects. Efficacy against DENV2 VCD was 80% in seropositive subjects, and 88% in seronegative subjects; against DENV3 VCD it was 52% in seropositive subjects and -16% in seronegative subjects; and against DENV4 VCD, 71% in seropositive subjects and -106% in seronegative subjects.

 

Against VCD requiring hospitalization 57 months after the first dose, efficacy was 67% in seropositive subjects and 78% in seronegative subjects for DENV1; 96% in seropositive subjects and 100% in seronegative subjects for DENV2; and 74% in seropositive subjects and -88% in seronegative subjects for DENV3.

 

For DENV4, cases numbered only 3 among seropositive subjects and 1 in seronegative subjects in the placebo group, compared to none in the vaccine group. This did not provide adequate power to estimate efficacy against DENV4 stratified by baseline serostatus.

 

So depending on which serotype you're taking about, the vaccine is up to 88% effective against infection and up to 100% effective against hospitalisation, in seronegative individuals.

Posted
3 hours ago, GroveHillWanderer said:

 

 

So depending on which serotype you're taking about, the vaccine is up to 88% effective against infection and up to 100% effective against hospitalisation, in seronegative individuals.

Except for type 4: "For DENV4, cases numbered only 3 among seropositive subjects and 1 in seronegative subjects in the placebo group, compared to none in the vaccine group. This did not provide adequate power to estimate efficacy against DENV4 stratified by baseline serostatus"

Posted
1 hour ago, JackGats said:

Except for type 4: "For DENV4, cases numbered only 3 among seropositive subjects and 1 in seronegative subjects in the placebo group, compared to none in the vaccine group. This did not provide adequate power to estimate efficacy against DENV4 stratified by baseline serostatus"

I said, "up to" those figures, depending on serotype. Which is accurate.

 

The figures for DENV4 in seronegative individuals could not be determined but based on the figures for their seropositive counterparts, would almost certainly be less than 88% for VCD and less than 100% for VCD requiring hospitalisation.

Posted

You should ask the question, do you want more vaccines? How do they work for you?!

It seems now more and more that the covid vaccines are killers.

 

"The most common illnesses occurring after vaccination were immune thrombocytopenia, myocarditis, and Guillain-Barré syndrome."

 

A man asked about the cure for the covid vaccines, as his healthy friend got paralyzed and seem to have the syndrome mentioned. This due to covid vaccines, he had.

 

The doctors answer: 

What happened with the vaccines is a premeditated crime. In the Netherlands, too, people are turning a blind eye to the excess mortality after vaccinations.

The first trials have started in the US.

There are indications from pathology that the Covid vaccine causes thrombosis in small, but sometimes also large vessels. Hence the multitude of serious side effects.

As far as treatment is concerned, the McCullough protocol seems to work, although it often takes a year or longer.

Here is the protocol again. Those who use anticoagulants must be careful, because Nattokinase also inhibits clotting.

In Japan, Nattokinase is used as an anticoagulant.

 

Some more news on thi9s site.

https://www.frontnieuws.com/noorwegen-onthult-doofpotaffaire-van-wereldwijde-toename-sterfgevallen-onder-covid-gevaccineerden/

Yes , in Dutch, however you can switch to English in the language box showed.

 

It is about the mrna vaccines for covid, so dengue vaccine the same?

Or. so what are effects of dengue vaccine when you already had the covid vaccines?

Im wondering on my medicines today as what are they now doing with me, together what covid vaccines have done? Imo they have to renew the medicines book completely, due to new situation, vaccination with covid vaccines.

Nothing is the same anymore.

It looks like the world will be shaken up with the new outcomes of covid vaccines and is the question should everyone have an "McCullough protocol" to get down the spikes of the protein?

Or yet too late and you'll have to find out if it passes your door.

A lot of persons got  the covid vaccines and I think they regret now. I regret.

Lots of things can happen with your body now and not for the better.

McCullough protocol, again you have a substance in body , fighting one thing, but what does it do further? Side effects? 

They have been wrong in the past, as with Softenon and DES, with quite a negative impact on the unborn.

SO you really want another new vaccine in your bloodstream?

 

Ok one  thing more, I asked gpt difference between virus and parasite:

The main difference between a virus and a parasite comes down to their biology and how they live:

  • Virus: A virus is non-living outside a host. It’s a tiny bit of genetic material (DNA or RNA) inside a protein coat. It can’t reproduce or carry out any life processes on its own—it has to invade a host cell and hijack its machinery to make more viruses.

  • Parasite: A parasite is a living organism (like a worm, protozoan, or insect) that lives in or on another organism (the host) and gets its food at the host’s expense. Parasites can reproduce on their own and carry out life functions.

So, vaccine dengue would not be on mrna scale, right? Phewww

Qdenga would be the one then, shown in wikipedia: https://en.wikipedia.org/wiki/Dengue_vaccine

However there are new ones.

Dengvaxia is not recommended if you didnt have dengue before.

In the Philippines, vaccination program (2017) went wrong and children were injected with Dengvaxia.

If you read that story then you scratch your head and think:  wtf 

830000 children vaccinated with it! A sort of "mistake" ,I think, but then in the way, experiment, money ! 

Show you again, how wrong it can go.

And so sure, that it was in the same way with the covid vaccinations. Money, lives DONT matter.

Enjoy, your live, as long as you can. There is imo another issue, more working, money.

 

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.



×
×
  • Create New...